VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary

VBI Vaccines

09/05/2022 15:22

* VBI Vaccines Inc  VBIV.OQ  reported a quarterly adjusted
loss
of 8 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 8 cents per share.
    * Revenue fell 58.1% to $126.00 thousand from a year ago; 
analysts expected $86.67 thousand. 
    * VBI Vaccines Inc's reported EPS for the quarter was a loss
of 8
cents​.
    * The mean earnings estimate of analysts had fallen by
about 14.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * VBI Vaccines Inc shares had fallen by 27.4% this
quarter and
lost 48.5% so far this year.
    * The company reported a quarterly loss of $21.25 million.
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $6.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 02:21 p.m.  ​All
figures in US dollars unless otherwise stated